| GPR4 |
GPR4, GPR19: Probable G-protein coupled receptor 4 |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.285 |
Evidence |
|
| GPR4 |
GPR4, GPR19: Probable G-protein coupled receptor 4 |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.285 |
Evidence |
|
| GPR4 |
GPR4, GPR19: Probable G-protein coupled receptor 4 |
CCL8 |
CCL8, MCP2, SCYA10, SCYA8: Small-inducible cytokine A8 precursor |
0.285 |
Evidence |
|
| RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
IFIH1 |
IFIH1, MDA5, RH116: Interferon-induced helicase C domain-containing protein 1 |
0.285 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
AMHR2 |
AMHR2, AMHR: Anti-Muellerian hormone type-2 receptor precursor |
0.285 |
Evidence |
|
| MC3R |
MC3R: Melanocortin receptor 3 |
ASIP |
ASIP, AGTI, AGTIL, ASP: Agouti-signaling protein precursor |
0.285 |
Evidence |
O
|
| TNFSF9 |
TNFSF9: Tumor necrosis factor ligand superfamily member 9 |
RTEL1 |
TNFRSF6B, DCR3, UNQ186/PRO212, TR6: Tumor necrosis factor receptor superfamily m |
0.285 |
Evidence |
|
| MNDA |
MNDA: Myeloid cell nuclear differentiation antigen |
BIRC2 |
BIRC2, API1, IAP2, MIHB, RNF48: Baculoviral IAP repeat-containing protein 2 |
0.285 |
Evidence |
|
| CTRL |
PSMB10, MECL1: Proteasome subunit beta type-10 precursor |
PLK3 |
PLK3, CNK, FNK, PRK: Serine/threonine-protein kinase PLK3 |
0.285 |
Evidence |
|
| ARL3 |
ARL3, ARFL3: ADP-ribosylation factor-like protein 3 |
EDG2 |
EDG2, LPA1: Lysophosphatidic acid receptor Edg-2 |
0.285 |
Evidence |
|
| ARL3 |
ARL3, ARFL3: ADP-ribosylation factor-like protein 3 |
CCR10 |
CCR10, GPR2: C-C chemokine receptor type 10 |
0.285 |
Evidence |
|
| HRH1 |
HRH1: Histamine H1 receptor |
CCL13 |
CCL13, MCP4, NCC1, SCYA13: Small-inducible cytokine A13 precursor |
0.285 |
Evidence |
|
| CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
CDH1 |
CDH1, CDHE, UVO: Epithelial cadherin precursor |
0.285 |
Evidence |
|
| PTGER1 |
PTGER1: Prostaglandin E2 receptor EP1 subtype |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
| RYK |
RYK, JTK5A: Tyrosine-protein kinase RYK precursor |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
0.285 |
Evidence |
|
| RYK |
RYK, JTK5A: Tyrosine-protein kinase RYK precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
0.285 |
Evidence |
|
| RYK |
RYK, JTK5A: Tyrosine-protein kinase RYK precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.285 |
Evidence |
|
| BRS3 |
BRS3: Bombesin receptor subtype-3 |
CCL17 |
CCL17, SCYA17, TARC: Small-inducible cytokine A17 precursor |
0.285 |
Evidence |
|
| SSTR4 |
SSTR4: Somatostatin receptor type 4 |
CXCL9 |
CXCL9, CMK, MIG, SCYB9: Small-inducible cytokine B9 precursor |
0.285 |
Evidence |
|
| GDI1 |
GDI1, GDIL, OPHN2, RABGDIA, XAP4: Rab GDP dissociation inhibitor alpha |
RAB2 |
RAB2, RAB2A: Ras-related protein Rab-2A |
0.285 |
Evidence |
|
| GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
ADRBK2 |
ADRBK2, BARK2, GRK3: Beta-adrenergic receptor kinase 2 |
0.285 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
RGS17 |
RGS17: Regulator of G-protein signaling 17 |
0.285 |
Evidence |
|
| ADORA2B |
ADORA2B: Adenosine receptor A2b |
CCL17 |
CCL17, SCYA17, TARC: Small-inducible cytokine A17 precursor |
0.285 |
Evidence |
|
| HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
CX3CL1 |
CX3CL1, A-152E5.2, FKN, NTT, SCYD1: Fractalkine precursor |
0.285 |
Evidence |
|
| HTR1D |
HTR1D, HTR1DA, HTRL: 5-hydroxytryptamine receptor 1D |
CCL27 |
CCL27, ILC, SCYA27: Small-inducible cytokine A27 precursor |
0.285 |
Evidence |
|